Wed, August 7, 2024

Mayank Mamtani Maintained (TGTX) at Strong Buy with Increased Target to $34 on, Aug 7th, 2024

Mayank Mamtani of B. Riley Securities, Maintained "TG Therapeutics, Inc." (TGTX) at Strong Buy with Increased Target from $29 to $34 on, Aug 7th, 2024.

Mayank has made no other calls on TGTX in the last 4 months.



There are 3 other peers that have a rating on TGTX. Out of the 3 peers that are also analyzing TGTX, 0 agree with Mayank's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Mayank


  • Edward White of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $49 on, Tuesday, August 6th, 2024
  • Matthew Kaplan of "Ladenburg Thalmann" Maintained at Strong Buy with Increased Target to $40 on, Thursday, May 2nd, 2024
  • Eric Joseph of "JP Morgan" Reiterated at Buy and Held Target at $25 on, Thursday, April 18th, 2024